TRILACICLIB

TRILACICLIB was reported 244 times

TRILACICLIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TISSUE INFILTRATION 2 0.0068
1 INTESTINAL SEPSIS 1 0.0038
2 SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0033
3 INFUSION SITE IRRITATION 4 0.0031
4 FEAR OF DEATH 7 0.0031
5 PERFORMANCE STATUS DECREASED 14 0.0030
6 ADMINISTRATION SITE REACTION 1 0.0026
7 PHLEBITIS 8 0.0016
8 BICYTOPENIA 3 0.0015
9 PROCEDURAL ANXIETY 1 0.0015
10 INFECTIOUS PLEURAL EFFUSION 2 0.0013
11 PSYCHIATRIC SYMPTOM 8 0.0011
12 GRANULOCYTE COUNT DECREASED 2 0.0011
13 WRONG SCHEDULE 1 0.0010
14 MYELOSUPPRESSION 37 0.0010
15 DEVICE RELATED THROMBOSIS 1 0.0010
16 INFUSION SITE PAIN 11 0.0009
17 INFUSION SITE REACTION 2 0.0007
18 INFUSION SITE ERYTHEMA 5 0.0006
19 HYPOPITUITARISM 1 0.0006
20 EXTRAVASATION 2 0.0005
21 FEBRILE BONE MARROW APLASIA 2 0.0005
22 CARDIAC FAILURE CHRONIC 2 0.0005
23 COLORECTAL CANCER METASTATIC 1 0.0004
24 GASTROINTESTINAL OBSTRUCTION 1 0.0004
25 PHYSICAL DECONDITIONING 1 0.0004
26 RED BLOOD CELL COUNT DECREASED 11 0.0004
27 IMMUNE-MEDIATED MYOSITIS 1 0.0004
28 CEREBRAL THROMBOSIS 1 0.0004
29 NON-CARDIAC CHEST PAIN 1 0.0003
30 NEAR DEATH EXPERIENCE 1 0.0003
31 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
32 CARDIAC FAILURE ACUTE 2 0.0003
33 BLOOD PHOSPHORUS DECREASED 1 0.0003
34 PROTEIN TOTAL DECREASED 1 0.0003
35 HYPERPYREXIA 1 0.0002
36 INTERCEPTED MEDICATION ERROR 1 0.0002
37 PULSE ABSENT 1 0.0002
38 INCORRECT DOSAGE ADMINISTERED 1 0.0002
39 VEIN DISORDER 1 0.0002
40 KLEBSIELLA INFECTION 1 0.0002
41 NEUTROPHIL COUNT DECREASED 8 0.0002
42 FAILURE TO THRIVE 1 0.0002
43 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
44 SKIN WARM 1 0.0002
45 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
46 PLATELET COUNT DECREASED 18 0.0002
47 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
48 INJECTION SITE EXTRAVASATION 2 0.0002
49 INFUSION SITE EXTRAVASATION 1 0.0002
50 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
51 NERVOUSNESS 8 0.0002
52 DEPRESSED MOOD 8 0.0002
53 HYPOPHOSPHATAEMIA 1 0.0001
54 BLOOD ALBUMIN DECREASED 1 0.0001
55 FRUSTRATION TOLERANCE DECREASED 1 0.0001
56 MYOSITIS 1 0.0001
57 PNEUMONIA BACTERIAL 1 0.0001
58 UROSEPSIS 1 0.0001
59 CHEST DISCOMFORT 11 0.0001
60 HAEMORRHAGE 11 0.0001
61 RESPIRATORY DISORDER 3 0.0001
62 BRAIN INJURY 1 0.0001
63 SEPSIS 11 0.0001
64 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
65 INJECTION SITE DISCOMFORT 1 0.0001
66 SUDDEN DEATH 1 0.0001
67 PULMONARY THROMBOSIS 1 0.0001
68 BLOOD CALCIUM DECREASED 1 0.0001
69 INFECTION 12 0.0001
70 CYTOPENIA 1 0.0001
71 HYPERCALCAEMIA 1 0.0001
72 ABNORMAL WEIGHT GAIN 1 0.0001
73 ILEUS 1 0.0001
74 INJECTION SITE DISCOLOURATION 1 0.0001
75 INJECTION SITE IRRITATION 1 0.0001
76 ADVERSE REACTION 1 0.0001
77 TACHYPNOEA 1 0.0001
78 PNEUMONITIS 2 0.0001
79 ANAEMIA 14 0.0001
80 INJECTION SITE REACTION 5 0.0001
81 BURNING SENSATION 5 0.0001
82 HYPOKALAEMIA 3 0.0001
83 FEBRILE NEUTROPENIA 4 0.0001
84 FACE OEDEMA 1 0.0001
85 NEUROTOXICITY 1 0.0001
86 DRUG ERUPTION 1 0.0001
87 PROTEINURIA 1 0.0001
88 PULMONARY FIBROSIS 1 0.0001
89 ACUTE RESPIRATORY FAILURE 1 0.0001
90 NEUTROPENIA 7 0.0001
91 PRODUCT PREPARATION ERROR 1 0.0000
92 PNEUMONIA 15 0.0000
93 PRODUCT PRESCRIBING ISSUE 1 0.0000
94 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
95 TRANSAMINASES INCREASED 1 0.0000
96 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
97 CHROMATURIA 1 0.0000
98 PRESYNCOPE 1 0.0000
99 CEREBRAL INFARCTION 1 0.0000
100 ALOPECIA 8 0.0000
101 LEUKOPENIA 2 0.0000
102 SOMNOLENCE 8 0.0000
103 EXPOSURE VIA SKIN CONTACT 1 0.0000
104 DIPLOPIA 1 0.0000
105 MUCOSAL INFLAMMATION 1 0.0000
106 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
107 CARDIAC FAILURE 3 0.0000
108 ANAPHYLACTIC REACTION 2 0.0000
109 HAEMOPTYSIS 1 0.0000
110 COUGH 10 0.0000
111 HYPONATRAEMIA 2 0.0000
112 INTENTIONAL DOSE OMISSION 1 0.0000
113 LIVER FUNCTION TEST ABNORMAL 1 0.0000
114 RENAL INJURY 1 0.0000
115 DYSPNOEA 19 0.0000
116 DRUG-INDUCED LIVER INJURY 1 0.0000
117 HYPOTHYROIDISM 1 0.0000
118 OFF LABEL USE 27 0.0000
119 DEEP VEIN THROMBOSIS 2 0.0000
120 INFUSION RELATED REACTION 2 0.0000
121 SYNCOPE 3 0.0000
122 FLUSHING 3 0.0000
123 WEIGHT DECREASED 8 0.0000
124 ANXIETY 8 0.0000
125 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
126 RESPIRATORY FAILURE 2 0.0000
127 HEPATIC FUNCTION ABNORMAL 1 0.0000
128 EPISTAXIS 2 0.0000
129 ASTHENIA 10 0.0000
130 HOT FLUSH 2 0.0000
131 PYREXIA 8 0.0000
132 MENTAL DISORDER 1 0.0000
133 PULMONARY EMBOLISM 2 0.0000
134 NEUROPATHY PERIPHERAL 2 0.0000
135 COMA 1 0.0000
136 ATRIAL FIBRILLATION 2 0.0000
137 DEATH 16 0.0000
138 MALAISE 8 0.0000
139 MEDICATION ERROR 1 0.0000
140 PANCYTOPENIA 1 0.0000
141 THROMBOCYTOPENIA 2 0.0000
142 OXYGEN SATURATION DECREASED 1 0.0000
143 PALPITATIONS 2 0.0000
144 DISEASE PROGRESSION 2 0.0000
145 FATIGUE 13 0.0000
146 STOMATITIS 1 0.0000
147 ILL-DEFINED DISORDER 1 0.0000
148 PLEURAL EFFUSION 1 0.0000
149 NAUSEA 13 0.0000
150 DISCOMFORT 1 0.0000
151 INJECTION SITE ERYTHEMA 2 0.0000
152 LOSS OF CONSCIOUSNESS 2 0.0000
153 SWELLING FACE 1 0.0000
154 DEHYDRATION 2 0.0000
155 HEPATIC ENZYME INCREASED 1 0.0000
156 PAIN 9 0.0000
157 ERYTHEMA 3 0.0000
158 HYPERTENSION 3 0.0000
159 SKIN BURNING SENSATION 1 0.0000
160 UNDERDOSE 1 0.0000
161 AGITATION 1 0.0000
162 HYPOAESTHESIA 2 0.0000
163 UNEVALUABLE EVENT 1 0.0000
164 INJECTION SITE PAIN 4 0.0000
165 DECREASED APPETITE 3 0.0000
166 VOMITING 6 0.0000
167 DIZZINESS 6 0.0000
168 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
169 RASH 5 0.0000
170 PRODUCT STORAGE ERROR 1 0.0000
171 MUSCULOSKELETAL STIFFNESS 1 0.0000
172 COVID-19 2 0.0000
173 MUSCLE SPASMS 2 0.0000
174 ADVERSE EVENT 1 0.0000
175 CHEST PAIN 2 0.0000
176 HYPERSENSITIVITY 2 0.0000
177 CARDIAC DISORDER 1 0.0000
178 SWELLING 1 0.0000
179 HEART RATE INCREASED 1 0.0000
180 HAEMOGLOBIN DECREASED 1 0.0000
181 CONSTIPATION 2 0.0000
182 INCORRECT DOSE ADMINISTERED 2 0.0000
183 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
184 ABDOMINAL PAIN 2 0.0000
185 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
186 VISUAL IMPAIRMENT 1 0.0000
187 HEADACHE 5 0.0000
188 RENAL FAILURE 1 0.0000
189 INSOMNIA 2 0.0000
190 PRODUCT QUALITY ISSUE 1 0.0000
191 PRODUCT DOSE OMISSION ISSUE 2 0.0000
192 PARAESTHESIA 1 0.0000
193 CONFUSIONAL STATE 1 0.0000
194 TREMOR 1 0.0000
195 URINARY TRACT INFECTION 1 0.0000
196 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
197 GAIT DISTURBANCE 1 0.0000
198 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
199 DIARRHOEA 3 0.0000
200 PAIN IN EXTREMITY 1 0.0000
201 DRUG INEFFECTIVE 4 0.0000
202 FALL 1 0.0000
203 PRURITUS 1 0.0000
204 ARTHRALGIA 1 0.0000